AdvisorShares Psychedelics ETF (PSIL) price, chart and fund profile
Price chart
Fund profile
PSIL is actively managed to provide exposure to the emerging global psychedelics industry.
- Issuer
- AdvisorShares
- Industry
- Healthcare
- Inception
- Sep 15, 2021
- Assets under management
- $56.3M
- Expense ratio
- 1.00%
- Net asset value
- $25.07
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- advisorshares.com↗
Frequently asked questions
What is AdvisorShares Psychedelics ETF (PSIL)?
PSIL is actively managed to provide exposure to the emerging global psychedelics industry.
What is PSIL's expense ratio?
AdvisorShares Psychedelics ETF charges an annual expense ratio of 1.00%. The fund is issued by AdvisorShares.
How large is PSIL?
AdvisorShares Psychedelics ETF manages $56.3M in assets and has traded since Sep 15, 2021.
How do I buy shares of AdvisorShares Psychedelics ETF (PSIL)?
PSIL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.